Capri Holdings CPRI 深 沪
已收盘 08-14 16:00:00 美东时间
15.34
-0.260
-1.67%
华盛通- 最 高15.90
- 今 开15.77
- 成交量 452.62万股
- 最 低 15.295
- 昨 收 15.60
- 总市值 17.43亿
- 52周最高 28.265
- 市盈率 静 19.98
- 换手率 3.98%
- 52周最低 14.775
- 委 比 81.82%
- 总股本 1.14亿
- 历史最高 72.37
- 量 比 0.95
- 振 幅 3.88%
- 历史最低 5.42
- 每 手 1
- 风险率 2.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Capricor surges on amended plans for lead drug
Shares of Capricor Therapeutics (CAPR) climbed more than 100% in the premarket on Friday after the cell therapy developer announced plans to submit an amended marketing application for its lead drug, ...
08-14 19:18
Capricorn Metals Plans Targeted Share Placement on ASX
The latest update is out from Capricorn Metals Ltd ( ($AU:CMM) ). Capricorn Met...
08-14 09:50
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
财报速睇 | Capri Holdings 2026财年Q2营收7.69亿美元，同比下降3.5%；归母净利润0.69亿美元，同比增长30.2%
华盛资讯8月6日讯，Capri Holdings公布2026财年Q2业绩，公司Q2营收7.69亿美元，同比下降3.5%，归母净利润0.69亿美元，同比增长30.2%。
08-06 09:37
财报速睇 | Capri Holdings 2026财年Q2营收7.69亿美元，同比下降3.5%；归母净利润0.69亿美元，同比增长30.2%
华盛资讯8月5日讯，Capri Holdings公布2026财年Q2业绩，公司Q2营收7.69亿美元，同比下降3.5%，归母净利润0.69亿美元，同比增长30.2%。
08-05 19:01
Capri Holdings Sees Q2 GAAP EPS $0.20 vs $0.44 Est; Sees Sales $780.000M vs $853.984M Est
Capri Holdings (NYSE:CPRI) is looking for Q2 GAAP EPS of $0.20 vs $0.44 analyst estimate. sees sales of $780.000 million vs $853.984 million analyst estimate.
08-05 18:46
Capri Holdings Q1 Adj. EPS $0.67 Beats $0.40 Estimate, Sales $769.000M Beat $752.680M Estimate
Capri Holdings (NYSE:CPRI) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.40 by 67.5 percent. This is a 34 percent increase over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $769.000 million which ...
08-05 18:45
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
JP Morgan Maintains Overweight on Capri Holdings, Lowers Price Target to $22
JP Morgan analyst Matthew Boss maintains Capri Holdings (NYSE:CPRI) with a Overweight and lowers the price target from $29 to $22.
08-04 18:39
Replimune surges on positive AdCom vote on lead drug
Replimune (REPL) shares more than doubled in post-market trading on Thursday after the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee voted in favor of the company’s lead asset, RP1. Th...
07-31 11:00
